BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 33099748)

  • 1. Increased Susceptibility of Atrial Fibrillation Induced by Hyperuricemia in Rats: Mechanisms and Implications.
    Wang D; Sun L; Zhang G; Liu Y; Liang Z; Zhao J; Yin S; Su M; Zhang S; Wei Y; Liu H; Liang D; Li Y
    Cardiovasc Toxicol; 2021 Mar; 21(3):192-205. PubMed ID: 33099748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colchicine prevents atrial fibrillation promotion by inhibiting IL-1β-induced IL-6 release and atrial fibrosis in the rat sterile pericarditis model.
    Wu Q; Liu H; Liao J; Zhao N; Tse G; Han B; Chen L; Huang Z; Du Y
    Biomed Pharmacother; 2020 Sep; 129():110384. PubMed ID: 32554248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrine reduces susceptibility to postinfarct atrial fibrillation in rats due to antifibrotic properties.
    Ma J; Ma S; Yin C; Wu H
    J Cardiovasc Electrophysiol; 2018 Apr; 29(4):616-627. PubMed ID: 29377366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrial fibrillation and its arrhythmogenesis associated with insulin resistance.
    Chan YH; Chang GJ; Lai YJ; Chen WJ; Chang SH; Hung LM; Kuo CT; Yeh YH
    Cardiovasc Diabetol; 2019 Sep; 18(1):125. PubMed ID: 31558158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of elevated uric acid on ventricular remodeling in infarcted rats with experimental hyperuricemia.
    Chen CC; Hsu YJ; Lee TM
    Am J Physiol Heart Circ Physiol; 2011 Sep; 301(3):H1107-17. PubMed ID: 21622823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor-β-mediated CD44/STAT3 signaling contributes to the development of atrial fibrosis and fibrillation.
    Chang SH; Yeh YH; Lee JL; Hsu YJ; Kuo CT; Chen WJ
    Basic Res Cardiol; 2017 Sep; 112(5):58. PubMed ID: 28871329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of natriuretic peptide clearance receptor attenuates TGF-β1-induced selective atrial fibrosis and atrial fibrillation.
    Rahmutula D; Zhang H; Wilson EE; Olgin JE
    Cardiovasc Res; 2019 Feb; 115(2):357-372. PubMed ID: 30239604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probucol prevents atrial remodeling by inhibiting oxidative stress and TNF-α/NF-κB/TGF-β signal transduction pathway in alloxan-induced diabetic rabbits.
    Fu H; Li G; Liu C; Li J; Wang X; Cheng L; Liu T
    J Cardiovasc Electrophysiol; 2015 Feb; 26(2):211-22. PubMed ID: 25199622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beneficial effects of tolvaptan on atrial remodeling induced by chronic intermittent hypoxia in rats.
    Zhang K; Ma Z; Wang W; Liu R; Zhang Y; Yuan M; Li G
    Cardiovasc Ther; 2018 Dec; 36(6):e12466. PubMed ID: 30203914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperuricemia and Atrial Fibrillation.
    Maharani N; Kuwabara M; Hisatome I
    Int Heart J; 2016 Jul; 57(4):395-9. PubMed ID: 27396561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DL-3-n-Butylphthalide reduces atrial fibrillation susceptibility by inhibiting atrial structural remodeling in rats with heart failure.
    Qiu H; Wu H; Ma J; Cao H; Huang L; Qiu W; Peng Y; Ding C
    Naunyn Schmiedebergs Arch Pharmacol; 2018 Mar; 391(3):323-334. PubMed ID: 29290021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased Susceptibility to Atrial Fibrillation Secondary to Atrial Fibrosis in Transgenic Goats Expressing Transforming Growth Factor-β1.
    Polejaeva IA; Ranjan R; Davies CJ; Regouski M; Hall J; Olsen AL; Meng Q; Rutigliano HM; Dosdall DJ; Angel NA; Sachse FB; Seidel T; Thomas AJ; Stott R; Panter KE; Lee PM; Van Wettere AJ; Stevens JR; Wang Z; MacLeod RS; Marrouche NF; White KL
    J Cardiovasc Electrophysiol; 2016 Oct; 27(10):1220-1229. PubMed ID: 27447370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HDAC (Histone Deacetylase) Inhibitor Valproic Acid Attenuates Atrial Remodeling and Delays the Onset of Atrial Fibrillation in Mice.
    Scholz B; Schulte JS; Hamer S; Himmler K; Pluteanu F; Seidl MD; Stein J; Wardelmann E; Hammer E; Völker U; Müller FU
    Circ Arrhythm Electrophysiol; 2019 Mar; 12(3):e007071. PubMed ID: 30879335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CTRP9 Ameliorates Atrial Inflammation, Fibrosis, and Vulnerability to Atrial Fibrillation in Post-Myocardial Infarction Rats.
    Liu M; Li W; Wang H; Yin L; Ye B; Tang Y; Huang C
    J Am Heart Assoc; 2019 Nov; 8(21):e013133. PubMed ID: 31623508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased α-Actinin-2 Expression in the Atrial Myocardium of Patients with Atrial Fibrillation Related to Rheumatic Heart Disease.
    Zhang L; Zhang N; Tang X; Liu F; Luo S; Xiao H
    Cardiology; 2016; 135(3):151-159. PubMed ID: 27344599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR‑101a‑3p overexpression prevents acetylcholine‑CaCl
    Zhu J; Zhu N; Xu J
    Mol Med Rep; 2021 Oct; 24(4):. PubMed ID: 34435649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NPR-C (Natriuretic Peptide Receptor-C) Modulates the Progression of Angiotensin II-Mediated Atrial Fibrillation and Atrial Remodeling in Mice.
    Jansen HJ; Mackasey M; Moghtadaei M; Liu Y; Kaur J; Egom EE; Tuomi JM; Rafferty SA; Kirkby AW; Rose RA
    Circ Arrhythm Electrophysiol; 2019 Jan; 12(1):e006863. PubMed ID: 30636477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MFGE8 attenuates Ang-II-induced atrial fibrosis and vulnerability to atrial fibrillation through inhibition of TGF-β1/Smad2/3 pathway.
    Ge Z; Chen Y; Wang B; Zhang X; Yan Y; Zhou L; Zhang Y; Xie Y
    J Mol Cell Cardiol; 2020 Feb; 139():164-175. PubMed ID: 31958465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pioglitazone attenuates inflammatory atrial fibrosis and vulnerability to atrial fibrillation induced by pressure overload in rats.
    Kume O; Takahashi N; Wakisaka O; Nagano-Torigoe Y; Teshima Y; Nakagawa M; Yufu K; Hara M; Saikawa T; Yoshimatsu H
    Heart Rhythm; 2011 Feb; 8(2):278-85. PubMed ID: 21034856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of irbesartan on development of atrial fibrosis and atrial fibrillation in a canine atrial tachycardia model with left ventricular dysfunction, association with p53.
    Kataoka N; Nishida K; Kinoshita K; Sakamoto T; Nakatani Y; Tsujino Y; Mizumaki K; Inoue H; Kinugawa K
    Heart Vessels; 2016 Dec; 31(12):2053-2060. PubMed ID: 27236656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.